Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non–small-cell lung cancer
- 1 January 2007
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 67 (1) , 187-195
- https://doi.org/10.1016/j.ijrobp.2006.09.033
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Accuracy of Helical Computed Tomography and [18F] Fluorodeoxyglucose Positron Emission Tomography for Identifying Lymph Node Mediastinal Metastases in Potentially Resectable Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2005
- FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigationHead & Neck, 2005
- Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?Radiotherapy and Oncology, 2004
- Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical reportInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Defining a radiotherapy target with positron emission tomographyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Four‐dimensional (4D) PET/CT imaging of the thoraxMedical Physics, 2004
- Performance evaluation of the new whole-body PET/CT scanner: Discovery STEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000